Omar Mirza
Internal Medicine · Noblesville, INNPI 1184200768
Payments from drug & device makers
Across 37 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$116
- AbbVie$97
- AstraZeneca$82
- Novo Nordisk$69
- Exact Sciences$48
- Astellas Pharma US Inc$39
- plus $212 from 10 others
What the payments were for
- Food & beverage$663100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 6 | $116 |
| AbbVie | 5 | $97 |
| AstraZeneca | 5 | $82 |
| Novo Nordisk | 4 | $69 |
| Exact Sciences | 3 | $48 |
| Astellas Pharma US Inc | 2 | $39 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| Amgen | 2 | $31 |
| Edwards Lifesciences | 1 | $29 |
| Medtronic | 1 | $22 |
| Corium, LLC | 1 | $19 |
| Tempus AI, Inc | 1 | $19 |
| Pfizer | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
How this compares
$663 in reported general payments places this provider in the 70th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan | 11 | $1,634 |
| Atorvastatin Calcium | 48 | $366 |
| Gabapentin | 14 | $204 |
| Amlodipine Besylate | 28 | $76 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $68 |
| Metformin Hcl ErMetformin Hcl | 16 | $66 |
| Lisinopril | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Noblesville
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.